Research analysts at SunTrust Banks Inc. began coverage on shares of Ekso Bionics Holdings, Inc. (OTC:EKSO) in a report released on Friday, reports. The brokerage set a “buy” rating on the stock.

Separately, B. Riley started coverage on shares of Ekso Bionics Holdings in a report on Friday, September 16th. They set a “buy” rating and a $8.00 price objective on the stock.

Shares of Ekso Bionics Holdings (OTC:EKSO) opened at 6.05 on Friday. The firm’s market capitalization is $99.41 million. Ekso Bionics Holdings has a 12 month low of $3.45 and a 12 month high of $10.08. The firm’s 50-day moving average is $4.37 and its 200 day moving average is $5.40.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Stock Target Prices

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with's FREE daily email newsletter.